CAR T-cell Therapy: Global Strategic Business Report

Report
179 Pages
December 2023
Region: Global
Global Industry Analysts, Inc
ID: 5139742

Quick Summary:

In the rapidly evolving and highly lucrative landscape of the global CAR T-cell Therapy market, staying abreast of the latest trends and industry developments is crucial for sustained growth. Our comprehensive Market Research Report, meticulously prepared by industry experts, offers deep insights into this burgeoning $9.6 billion field, providing you with competitive knowledge to optimize your strategic planning and decision-making.

This report conducts an in-depth analysis on a range of key metrics, including anticipated growth rates, key geographical markets, and a snapshot of significant competitors. Inclusive of unique market presence data across multiple geographies, it affords a detailed view into the industry's terrain. Moreover, subscribers will benefit from online interactive peer-to-peer collaborative bespoke updates, access to a robust digital research platform, and complimentary updates for one year, securing a real-time tactical advantage in this dynamic field.

Global CAR T-cell Therapy Market to Reach $9.6 Billion by 2030

The global market for CAR T-cell Therapy estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$9.6 Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2022-2030. DLBCL, one of the segments analyzed in the report, is projected to record 18.7% CAGR and reach US$4.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the ALL segment is readjusted to a revised 25.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $610.5 Million, While China is Forecast to Grow at 21.4% CAGR

The CAR T-cell Therapy market in the U.S. is estimated at US$610.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.9% and 18.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 15.3% CAGR.

Select Competitors (Total 12 Featured) -

bluebird bio, Inc.
CARsgen Therapeutics
Celgene Corporation
Gilead Sciences, Inc.
Novartis AG

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

Frequently Asked Questions about the Global Market for CAR T-cell Therapy

What is the estimated value of the Global Market for CAR T-cell Therapy?

The Global Market for CAR T-cell Therapy was estimated to be valued at $2 Billion in 2022.

What is the growth rate of the Global Market for CAR T-cell Therapy?

The growth rate of the Global Market for CAR T-cell Therapy is 21.7%, with an estimated value of $9.6 Billion by 2030.

What is the forecasted size of the Global Market for CAR T-cell Therapy?

The Global Market for CAR T-cell Therapy is estimated to be worth $9.6 Billion by 2030.

Who are the key companies in the Global Market for CAR T-cell Therapy?

Key companies in the Global Market for CAR T-cell Therapy include bluebird bio, Inc., CARsgen Therapeutics, Celgene Corporation, Gilead Sciences, Inc. and Novartis AG.

Report Attribute	Details
No. of Pages	179
Published	December 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 2 Billion
Forecasted Market Value ( USD ) by 2030	$ 9.6 Billion
Compound Annual Growth Rate	21.7%
Regions Covered	Global

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
CAR T-cell Therapy - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World CAR T-cell Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for CAR T-cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 3: World 8-Year Perspective for CAR T-cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for DLBCL by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 5: World 8-Year Perspective for DLBCL by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 6: World Recent Past, Current & Future Analysis for ALL by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 7: World 8-Year Perspective for ALL by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for MM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 9: World 8-Year Perspective for MM by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for CLL by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 11: World 8-Year Perspective for CLL by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 12: World Recent Past, Current & Future Analysis for FL by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 13: World 8-Year Perspective for FL by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 14: USA Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 15: USA 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

CANADA

Table 16: Canada Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 17: Canada 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

JAPAN

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 18: Japan Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 19: Japan 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

CHINA

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 20: China Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 21: China 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

EUROPE

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 22: Europe Recent Past, Current & Future Analysis for CAR T-cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 23: Europe 8-Year Perspective for CAR T-cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
Table 24: Europe Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 25: Europe 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

FRANCE

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 26: France Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 27: France 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

GERMANY

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 28: Germany Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 29: Germany 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

ITALY

Table 30: Italy Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 31: Italy 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

UNITED KINGDOM

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 32: UK Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 33: UK 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

REST OF EUROPE

Table 34: Rest of Europe Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 35: Rest of Europe 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

ASIA-PACIFIC

CAR T-cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 36: Asia-Pacific Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 37: Asia-Pacific 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

REST OF WORLD

Table 38: Rest of World Recent Past, Current & Future Analysis for CAR T-cell Therapy by Indication - DLBCL, ALL, MM, CLL and FL - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 39: Rest of World 8-Year Perspective for CAR T-cell Therapy by Indication - Percentage Breakdown of Value Sales for DLBCL, ALL, MM, CLL and FL for the Years 2023 & 2030

IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

bluebird bio, Inc.
CARsgen Therapeutics
Celgene Corporation
Gilead Sciences, Inc.
Novartis AG

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4761EUR$4,950USD£4,083GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9046EUR$9,405USD£7,757GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14283EUR$14,850USD£12,248GBP

Quick Summary:

Global CAR T-cell Therapy Market to Reach $9.6 Billion by 2030

The U.S. Market is Estimated at $610.5 Million, While China is Forecast to Grow at 21.4% CAGR

Select Competitors (Total 12 Featured) -

What's New?

What is the estimated value of the Global Market for CAR T-cell Therapy?

What is the growth rate of the Global Market for CAR T-cell Therapy?

What is the forecasted size of the Global Market for CAR T-cell Therapy?

Who are the key companies in the Global Market for CAR T-cell Therapy?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Global T-Cell Therapy Market by Modality (Commercialized, Research), Therapy Type (CAR T-cell Therapy, T Cell Receptor-Based, Tumor Infiltrating Lymphocytes-Based), Indication - Forecast 2023-2030

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single-Use Equipment), Process (Cell Processing, Preservation), Cell type (T-Cells, Stem cells), End User (Biopharma, CROs, CMOs), Region - Global Forecast to 2028

Genomics - Global Strategic Business Report

Oncology Drugs Global Market Opportunities and Strategies to 2032

Global T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030